Ken Griffin acquired 10.2 Thousand Neurocrine Biosciences shares worth $1.41 Million. That's 0.00% of their equity portfolio (2548th largest holding). The first Neurocrine Biosciences trade was made in Q2 2013. Since then Ken Griffin bought shares 55 more times and sold shares on 44 occasions. The stake costed the investor $813 Thousand, netting the investor a gain of 73% so far.